UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Creation and validation of models to predict response to primary treatment in serous ovarian cancer

Scientific reports, 2021-03, Vol.11 (1), p.5957-5957, Article 5957

2021

Volltextzugriff (PDF)

Analysis of Chemotherapeutic Response in Ovarian Cancers Using Publicly Available High-Throughput Data

Cancer research (Chicago, Ill.), 2014-07, Vol.74 (14), p.3902-3912

2014

Volltextzugriff (PDF)

The impact of multi-modal therapy on survival for uterine carcinosarcomas

Gynecologic oncology, 2010-03, Vol.116 (3), p.419-423

2010

Volltextzugriff (PDF)

Prediction of chemo-response in serous ovarian cancer

Molecular cancer, 2016-10, Vol.15 (1), p.66-66, Article 66

2016

Volltextzugriff (PDF)

FGFR2 mutations promote endometrial cancer progression through dual engagement of EGFR and Notch signalling pathways

Clinical and translational medicine, 2023-05, Vol.13 (5), p.e1223-n/a

2023

Volltextzugriff (PDF)

A Prediction Model for Preoperative Risk Assessment in Endometrial Cancer Utilizing Clinical and Molecular Variables

International journal of molecular sciences, 2019-03, Vol.20 (5), p.1205

2019

Volltextzugriff (PDF)

Association of Distance to Gynecologic Oncologist and Survival in a Rural Midwestern State

Women's health reports (New Rochelle, N.Y.), 2022-08, Vol.3 (1), p.678-685

2022

Volltextzugriff (PDF)

Current Issues in the Management of Endometrial Cancer

Mayo Clinic proceedings, 2008, Vol.83 (1), p.97-112

2008

Volltextzugriff (PDF)

MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress

Molecular cancer, 2014-05, Vol.13 (1), p.129-129, Article 129

2014

Volltextzugriff (PDF)

Investigating the effect of optimal cytoreduction in the context of platinum sensitivity in high‐grade serous ovarian cancer

Acta obstetricia et gynecologica Scandinavica, 2022-10, Vol.101 (10), p.1085-1092

2022

Volltextzugriff (PDF)

Genomic characterization of five commonly used endometrial cancer cell lines

International journal of oncology, 2020-12, Vol.57 (6), p.1348-1357

2020

Volltextzugriff (PDF)

Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer

Gynecologic oncology, 2009-07, Vol.114 (1), p.3-11

2009

Volltextzugriff (PDF)

A nuclear polymorphism at the 8q24 region is associated with improved survival time and chemo‑response in high‑grade serous ovarian cancer

Oncology letters, 2021-10, Vol.22 (4), p.1, Article 733

2021

Volltextzugriff (PDF)

Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes

Carcinogenesis (New York), 2010-05, Vol.31 (5), p.827-833

2010

Volltextzugriff (PDF)

Integration of Genomic and Clinical Retrospective Data to Predict Endometrioid Endometrial Cancer Recurrence

International journal of molecular sciences, 2022-12, Vol.23 (24), p.16014

2022

Volltextzugriff (PDF)

Identification of Novel lncRNAs in Ovarian Cancer and Their Impact on Overall Survival

International journal of molecular sciences, 2021-01, Vol.22 (3), p.1079

2021

Volltextzugriff (PDF)

ECPPF (E2F1, CCNA2, POLE, PPP2R1A, FBXW7) stratification: Profiling high-risk subtypes of histomorphologically low-risk and treatment-insensitive endometrioid endometrial cancer

PloS one, 2022-12, Vol.17 (12), p.e0278408-e0278408

2022

Volltextzugriff (PDF)

Using Genomic Variation to Distinguish Ovarian High-Grade Serous Carcinoma from Benign Fallopian Tubes

International journal of molecular sciences, 2022-11, Vol.23 (23), p.14814

2022

Volltextzugriff (PDF)

Epigenetic-mediated upregulation of progesterone receptor B gene in endometrial cancer cell lines

Gynecologic oncology, 2005-10, Vol.99 (1), p.135-141

2005

Volltextzugriff (PDF)

Patterns of inguinal groin metastases in squamous cell carcinoma of the vulva

Gynecologic oncology, 2007-06, Vol.105 (3), p.742-746

2007

Volltextzugriff (PDF)

Microbial Communities in Gynecological Cancers and Their Association with Tumor Somatic Variation

Cancers, 2023-06, Vol.15 (13), p.3316

2023

Volltextzugriff (PDF)

Identification of Novel Fusion Transcripts in High Grade Serous Ovarian Cancer

International journal of molecular sciences, 2021-04, Vol.22 (9), p.4791

2021

Volltextzugriff (PDF)

High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group study

Gynecologic oncology, 2017-08, Vol.146 (2), p.247-253

2017

Volltextzugriff (PDF)

Prognostic stratification of endometrial cancers with high microsatellite instability or no specific molecular profile

Frontiers in oncology, 2023-05, Vol.13, p.1105504

2023

Volltextzugriff (PDF)

Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group study

Gynecologic oncology, 2017-12, Vol.147 (3), p.648-653

2017

Volltextzugriff (PDF)

1 – 25 von 117

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(112)

Publikationsform

Artikel
(117)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Creation and validation of models to predict response to primary treatment in serous ovarian cancer

Analysis of Chemotherapeutic Response in Ovarian Cancers Using Publicly Available High-Throughput Data

The impact of multi-modal therapy on survival for uterine carcinosarcomas

Prediction of chemo-response in serous ovarian cancer

FGFR2 mutations promote endometrial cancer progression through dual engagement of EGFR and Notch signalling pathways

A Prediction Model for Preoperative Risk Assessment in Endometrial Cancer Utilizing Clinical and Molecular Variables

Association of Distance to Gynecologic Oncologist and Survival in a Rural Midwestern State

Current Issues in the Management of Endometrial Cancer

MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress

Investigating the effect of optimal cytoreduction in the context of platinum sensitivity in high‐grade serous ovarian cancer

Genomic characterization of five commonly used endometrial cancer cell lines

Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer

A nuclear polymorphism at the 8q24 region is associated with improved survival time and chemo‑response in high‑grade serous ovarian cancer

Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes

Integration of Genomic and Clinical Retrospective Data to Predict Endometrioid Endometrial Cancer Recurrence

Identification of Novel lncRNAs in Ovarian Cancer and Their Impact on Overall Survival

ECPPF (E2F1, CCNA2, POLE, PPP2R1A, FBXW7) stratification: Profiling high-risk subtypes of histomorphologically low-risk and treatment-insensitive endometrioid endometrial cancer

Using Genomic Variation to Distinguish Ovarian High-Grade Serous Carcinoma from Benign Fallopian Tubes

Epigenetic-mediated upregulation of progesterone receptor B gene in endometrial cancer cell lines

Patterns of inguinal groin metastases in squamous cell carcinoma of the vulva

Microbial Communities in Gynecological Cancers and Their Association with Tumor Somatic Variation

Identification of Novel Fusion Transcripts in High Grade Serous Ovarian Cancer

High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group study

Prognostic stratification of endometrial cancers with high microsatellite instability or no specific molecular profile

Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group study

Aktive Filter

Suchergebnisse filtern